Category: Parkinson’s News

Host a ‘Time for Tea’ afternoon and help raise vital funds for Cure Parkinson’s in our 20th year. Whilst we’re not celebrating, we are making sure to mark

NEARLY ONE million Americans are living with Parkinson’s disease (PD), a progressive neurological disorder that affects movement and coordination. Every year, about 60,000 new cases are diagnosed in the United States, and approximately 10 million…

We recently published a list of Top 10 AI News Updates Taking Wall Street By Storm. In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against other top AI news updates taking Wall Street by storm. Escalating costs for developing bigger and more powerful artificial models has […]

Angels On Call Homecare proudly announces its recognition as a Community Partner in Parkinson’s Care by the Parkinson’s Foundation. This prestigious membership program enhances the quality of care for individuals with Parkinson’s disease (PD). This partnership underscores Angels On Call’s commitment to providing specialized, compassionate care that empowers clients to live with dignity and purpose.

Former Texas A&M basketball coach Billy Kennedy has spent his career developing game plans, mentoring players and leading teams through the highs and lows of competition. But in 2011, he faced an unexpected opponent in Parkinson’s disease, and he found hope in a place he jokingly calls “enemy territory” — the University of Kentucky.

Despite being a mainstay of Parkinson’s disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment.

The Parkinson’s support group gathered to offer a platform for members to share, support, and connect with one another.

A recent study reveals an immune mechanism that could explain why Parkinson’s disease affects more men than women. This…

Solving a decades-long mystery.

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson’s and CNS treatments.